Profile data is unavailable for this security.
About the company
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
- Revenue in USD (TTM)2.09m
- Net income in USD-5.49m
- Incorporated2016
- Employees13.00
- LocationNutriband Inc121 S Orange Ave Ste 1500ORLANDO 32801-3241United StatesUSA
- Phone+1 (407) 377-6695
- Websitehttps://nutriband.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Icecure Medical Ltd | 3.23m | -14.65m | 47.10m | 71.00 | -- | 3.87 | -- | 14.59 | -0.3211 | -0.3211 | 0.0708 | 0.266 | 0.1386 | 0.7518 | 35.68 | 45,478.88 | -62.89 | -54.89 | -76.33 | -68.66 | 40.26 | 49.87 | -453.76 | -313.19 | 3.08 | -- | 0.00 | -- | 4.67 | 23.50 | 13.70 | -- | 48.10 | -- |
| Lucid Diagnostics Inc | 2.98m | -54.53m | 47.73m | 70.00 | -- | -- | -- | 16.00 | -1.27 | -1.27 | 0.0698 | 0.2544 | 0.0735 | -- | 78.50 | 42,614.29 | -115.88 | -- | -248.82 | -- | -111.06 | -- | -1,576.63 | -- | 1.36 | -- | 0.5579 | -- | 544.03 | -- | 6.24 | -- | -- | -- |
| LENSAR Inc | 44.50m | -12.27m | 47.75m | 130.00 | -- | 1.50 | -- | 1.07 | -1.13 | -1.13 | 3.92 | 4.00 | 0.7536 | 1.32 | 9.79 | 342,307.70 | -20.78 | -30.97 | -25.12 | -36.94 | 50.45 | 51.04 | -27.57 | -52.30 | 2.36 | -- | 0.00 | -- | 19.25 | 11.57 | 27.77 | -- | -42.91 | -- |
| Cytosorbents Corp | 36.69m | -27.54m | 48.88m | 186.00 | -- | 2.58 | -- | 1.33 | -0.5869 | -0.5869 | 0.7748 | 0.3486 | 0.7019 | 4.82 | 5.97 | 197,237.50 | -52.69 | -36.00 | -68.27 | -43.52 | 64.08 | 68.15 | -75.07 | -62.71 | 1.21 | -114.70 | 0.1896 | -- | 4.79 | 10.06 | 13.12 | -- | -9.24 | -- |
| Beyond Air Inc | 689.00k | -66.70m | 50.72m | 98.00 | -- | 1.88 | -- | 73.61 | -2.13 | -2.13 | 0.0219 | 0.5867 | 0.011 | 1.44 | 1.24 | 7,030.61 | -112.64 | -70.88 | -148.49 | -88.69 | -115.24 | -- | -10,288.68 | -1,530.31 | 3.26 | -- | 0.382 | -- | -- | -- | -29.27 | -- | -- | -- |
| DarioHealth Corp | 19.04m | -59.90m | 52.66m | 276.00 | -- | 0.664 | -- | 2.77 | -2.04 | -2.04 | 0.633 | 2.65 | 0.1555 | 2.34 | 3.57 | 69,000.00 | -43.90 | -73.26 | -51.33 | -87.59 | 27.56 | 29.54 | -282.38 | -293.54 | 2.67 | -- | 0.2673 | -- | -26.41 | 22.45 | 0.5091 | -- | 52.42 | -- |
| Envoy Medical Inc | 297.00k | -22.43m | 54.10m | 34.00 | -- | -- | -- | 182.14 | -2.21 | -2.21 | 0.0194 | -0.3782 | 0.0494 | 0.4737 | 2.36 | 8,735.29 | -381.38 | -- | -2,885.46 | -- | -118.18 | -- | -7,718.86 | -- | 0.8969 | -16.54 | -- | -- | 33.33 | -- | -87.83 | -- | -- | -- |
| Apyx Medical Corp | 50.45m | -22.81m | 55.43m | 252.00 | -- | 2.74 | -- | 1.10 | -0.6583 | -0.6583 | 1.46 | 0.5846 | 0.7914 | 1.77 | 4.49 | 200,202.40 | -35.94 | -25.24 | -46.73 | -29.97 | 63.70 | 66.11 | -45.41 | -46.00 | 4.94 | -9.21 | 0.6207 | -- | 17.61 | 25.82 | 19.28 | -- | 7.99 | -- |
| Nutriband Inc | 2.09m | -5.49m | 55.95m | 13.00 | -- | 7.02 | -- | 26.83 | -0.6863 | -0.6863 | 0.2622 | 0.7267 | 0.2457 | 6.15 | 15.94 | -- | -64.63 | -55.21 | -72.05 | -66.74 | 41.34 | 33.32 | -263.05 | -315.87 | 0.854 | -82.63 | 0.0312 | -- | 0.2741 | 53.43 | -22.35 | -- | 65.57 | -- |
| Milestone Scientific Inc | 9.48m | -7.06m | 57.92m | 17.00 | -- | 7.70 | -- | 6.11 | -0.0948 | -0.0948 | 0.1265 | 0.0974 | 0.8025 | 0.7756 | 12.04 | 557,570.60 | -60.13 | -55.48 | -80.86 | -74.72 | 69.42 | 63.97 | -74.93 | -88.94 | 1.80 | -- | 0.0011 | -- | 11.60 | 0.4233 | 20.41 | -- | -7.99 | -- |
| Medinotec Inc | 3.05m | -566.90k | 58.67m | 29.00 | -- | 28.27 | -- | 19.24 | -0.0483 | -0.0483 | 0.2598 | 0.1769 | 0.6712 | 2.06 | 16.96 | 105,130.70 | -12.48 | -- | -13.23 | -- | 53.56 | -- | -18.59 | -- | 8.57 | 1.44 | 0.4323 | -- | -3.91 | -- | -184.47 | -- | -- | -- |
| Vivos Inc | 18.00k | -3.20m | 58.95m | 10.00 | -- | 43.94 | -- | 3,275.11 | -0.0087 | -0.0087 | 0.00005 | 0.0034 | 0.0127 | -- | 3.13 | -- | -225.38 | -202.25 | -235.64 | -552.77 | -33.33 | 10.79 | -17,805.45 | -11,969.07 | -- | -- | 0.00 | -- | -46.58 | -- | -17.19 | -- | -- | -- |
| Alpha Pro Tech, Ltd. | 60.92m | 4.21m | 59.38m | 124.00 | 14.13 | 0.9372 | 11.55 | 0.9748 | 0.3596 | 0.3596 | 5.22 | 5.42 | 0.8908 | 1.68 | 8.21 | 491,250.00 | 6.16 | 15.21 | 6.33 | 16.06 | 38.19 | 40.23 | 6.92 | 12.93 | 15.31 | -- | 0.00 | 0.00 | -1.21 | 5.60 | 27.64 | 2.93 | 5.50 | -- |
| Hyperfine Inc | 11.69m | -41.93m | 63.29m | 131.00 | -- | 0.8368 | -- | 5.41 | -0.5858 | -0.5858 | 0.1633 | 1.05 | 0.1127 | 1.03 | 2.80 | 89,251.91 | -40.40 | -- | -43.95 | -- | 42.39 | -- | -358.59 | -- | 8.26 | -- | 0.00 | -- | 61.90 | -- | 39.54 | -- | -- | -- |
| InspireMD Inc | 6.48m | -22.69m | 63.32m | 65.00 | -- | 1.69 | -- | 9.78 | -0.7594 | -0.7594 | 0.2108 | 1.50 | 0.2091 | 2.34 | 4.97 | 99,646.16 | -73.26 | -60.59 | -86.14 | -72.97 | 26.65 | 20.46 | -350.35 | -334.78 | 7.41 | -- | 0.00 | -- | 20.00 | 11.50 | -7.71 | -- | 41.57 | -- |
| Monogram Technologies Inc | 365.00k | -13.39m | 64.61m | 28.00 | -- | -- | -- | 177.01 | -0.4414 | -0.4414 | 0.012 | -- | 0.0316 | -- | -- | 13,035.71 | -115.81 | -119.26 | -226.52 | -257.40 | 0.00 | -- | -3,669.37 | -5,045.60 | -- | -- | 0.00 | -- | -- | -- | -0.3964 | -- | -15.97 | -- |
Data as of May 24 2024. Currency figures normalised to Nutriband Inc's reporting currency: US Dollar USD
3.20%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 86.80k | 1.11% |
| Geode Capital Management LLCas of 31 Mar 2024 | 58.57k | 0.75% |
| RBC Capital Markets LLC (Investment Management)as of 31 Mar 2024 | 35.00k | 0.45% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 17.27k | 0.22% |
| Virtu Americas LLCas of 31 Mar 2024 | 12.86k | 0.16% |
| Farther Finance Advisors LLCas of 31 Mar 2024 | 11.64k | 0.15% |
| AlphaQ Advisors LLCas of 31 Mar 2024 | 11.62k | 0.15% |
| Western International Securities, Inc.as of 31 Mar 2024 | 10.93k | 0.14% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Mar 2024 | 3.10k | 0.04% |
| Tower Research Capital LLCas of 31 Mar 2024 | 3.06k | 0.04% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
